GlassScriptPhysician profile
Carl Wingo
NPI 1700889664
$860.79
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $25.24 · 2021: $254.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $253.85 | 2021 | |
| Abbvie INC. | $102.05 | 2019 | |
| Duchesnay USA Incorporated | $77.37 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.79 | 2019 | |
| Daiichi Sankyo INC. | $38.35 | 2019 | |
| Amgen INC. | $36.04 | 2019-2020 | |
| Roche Diagnostics Corporation | $34.80 | 2019 | |
| Vertical Pharmaceuticals, LLC | $29.28 | 2019 | |
| Exeltis, USA INC. | $28.80 | 2019 | |
| Avion Pharmaceuticals | $26.58 | 2019 | |
| Allergan, INC. | $25.27 | 2019 | |
| Lupin INC. | $23.21 | 2019 | |
| Mylan Pharmaceuticals INC. | $23.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $18.68 | 2019 | |
| Avanos Medical | $17.68 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $15.60 | 2019 | |
| Coopersurgical, INC. | $14.79 | 2019 | |
| Hologic Sales and Service, LLC | $14.42 | 2019 | |
| Radius Health, INC. | $14.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Wingo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.